Caricamento...
Pharmacokinetics of intravenous telavancin in healthy subjects with varying degrees of renal impairment
PURPOSE: We evaluated the effect of renal impairment (RI) on the pharmacokinetics of telavancin and hydroxypropylbetadex (excipient in the telavancin drug product). METHODS: Adults with normal, mild, moderate or severe RI or end-stage renal disease (ESRD) receiving haemodialysis were included in two...
Salvato in:
| Pubblicato in: | Eur J Clin Pharmacol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Berlin Heidelberg
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4430595/ https://ncbi.nlm.nih.gov/pubmed/25939708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-015-1847-6 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|